Clinical Trial Update: Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rivaroxaban for preventing deep vein thrombosis in patients with May-Thurner Syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• May-thurner Syndrome

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: May-Thurner Syndrome | Phase 3 | Status: RECRUITING